Therapeutics

Inflammation

  • Study completed / Planned end date
  • Planned end date unavailable
  • Study aborted
Inflammation 2001 2002 2003 2004 2005 2006 2007 2008 2009 2010 2011 2012 2013 2014 2015 2016 2017 2018 2019 2020
ALZT-OP1
Phase 3
Azeliragon
Phase 3
CHF 5074
Phase 2
Gamunex
Phase 2/3
Neflamapomid
Phase 2
Octagam®10%
Phase 2
Pioglitazone
Phase 2, Phase 3
Sargramostim
Phase 2
Thalidomide
Phase 2/3